Dr. Perez-Leal’s research centers on the development of innovative molecular tools to elucidate human disease mechanisms and advance therapeutic discovery. His laboratory has pioneered CRISPR-based genome editing methodologies, emphasizing the creation of sophisticated cellular models for real-time analysis of complex biological processes. A key contribution is the development of the patented FAST-HDR system, a breakthrough technology that enables CRISPR-mediated multiplex gene tagging with fluorescent proteins to generate cellular models for live-cell drug discovery. This platform has been successfully applied to study autophagy, lysosomal storage disorders, and drug toxicity. Currently, his efforts are directed toward refining FAST-HDR to improve its compatibility with induced pluripotent stem cells, thereby facilitating the creation of cellular models that extend beyond the capabilities of conventional laboratory cell lines.
Dr. Perez-Leal’s research centers on the development of innovative molecular tools to elucidate human disease mechanisms and advance therapeutic discovery. His laboratory has pioneered CRISPR-based genome editing methodologies, emphasizing the creation of sophisticated cellular models for real-time analysis of complex biological processes. A key contribution is the development of the patented FAST-HDR system, a breakthrough technology that enables CRISPR-mediated multiplex gene tagging with fluorescent proteins to generate cellular models for live-cell drug discovery. This platform has been successfully applied to study autophagy, lysosomal storage disorders, and drug toxicity. Currently, his efforts are directed toward refining FAST-HDR to improve its compatibility with induced pluripotent stem cells, thereby facilitating the creation of cellular models that extend beyond the capabilities of conventional laboratory cell lines.